The senior leaders of the Consortium include sixteen individuals: The Director, the Deputy Director, ten Associate Directors, the Consortium Administrator, and three Deputy Associate Directors. The Associate Directors provide oversight and coordination of the Consortium's scientific disciplines of basic sciences, clinical sciences, and public health sciences. They co-direct the oversight and coordination of various Consortium processes, including planning and evaluation, shared resources, membership, and allocation of developmental funds. In addition, they serve as institutional representatives. The three independent institutions in the Consortium have different cultures and locations, so these individuals have a strong communication role to ensure that the members within their institutions are aware of activities and issues of the Consortium. In addition to representing the interests of the Consortium at their institutions, they also represent the interests of their institutions within the Consortium. The Deputy Associate Directors leaders are responsible for scientific planning for the Consortium, formation and management of the Consortium interdisciplinary goals for coordinating internal program review, shared resources review, and review of pilot funding. These functions are accomplished through their leadership of the Consortium Scientific Steering Committee, in which they enlist the help and support of the Consortium program leaders for these activities. The Consortium Administrator is responsible for implementation of the Consortium goals and objectives, and coordination of Consortium and CCSG administrative and management support activities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA015704-39S1
Application #
8607290
Study Section
Subcommittee G - Education (NCI)
Project Start
2013-01-01
Project End
2013-12-31
Budget Start
2013-01-01
Budget End
2013-12-31
Support Year
39
Fiscal Year
2013
Total Cost
$109,383
Indirect Cost
$47,234
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Morris, S M; Carter, K T; Baek, J Y et al. (2015) TGF-? signaling alters the pattern of liver tumorigenesis induced by Pten inactivation. Oncogene 34:3273-82
Briant, Katherine Josa; Espinoza, Noah; Galvan, Avigail et al. (2015) An innovative strategy to reach the underserved for colorectal cancer screening. J Cancer Educ 30:237-43
Toledo, Chad M; Herman, Jacob A; Olsen, Jonathan B et al. (2014) BuGZ is required for Bub3 stability, Bub1 kinetochore function, and chromosome alignment. Dev Cell 28:282-94
Klippel, Z K; Chou, J; Towlerton, A M et al. (2014) Immune escape from NY-ESO-1-specific T-cell therapy via loss of heterozygosity in the MHC. Gene Ther 21:337-42
Mielcarek, Marco; Kirkorian, Anna Yasmine; Hackman, Robert C et al. (2014) Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation. Transplantation 98:563-8
Luo, Yanxin; Wong, Chao-Jen; Kaz, Andrew M et al. (2014) Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology 147:418-29.e8
Cermelli, Silvia; Jang, In Sock; Bernard, Brady et al. (2014) Synthetic lethal screens as a means to understand and treat MYC-driven cancers. Cold Spring Harb Perspect Med 4:
Rizzardi, Anthony E; Rosener, Nikolaus K; Koopmeiners, Joseph S et al. (2014) Evaluation of protein biomarkers of prostate cancer aggressiveness. BMC Cancer 14:244
Vainstein, V; Buckley, S A; Shukron, O et al. (2014) Rapid rate of peripheral blood blast clearance accurately predicts complete remission in acute myeloid leukemia. Leukemia 28:713-6
Laszlo, George S; Ries, Rhonda E; Gudgeon, Chelsea J et al. (2014) High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Leuk Lymphoma 55:2817-21

Showing the most recent 10 out of 300 publications